sangart.com - information about domain
- Server Status: available
- Server IP: 74.124.210.252
- Server Response Time: 363ms
Site title
Sangart
Alexa information
Alexa rank: 8,830,218
Rank Trend
Bounce Trend
DNS Information
| Host: | Class: | Type: | IP: | TTL: | Target: | Other: |
| sangart.com | IN | MX | 86400 | mail.sangart.com | pri: 10 | |
| sangart.com | IN | A | 74.124.210.252 | 86400 | ||
| sangart.com | IN | SOA | 86400 | mname: dbru.br.ns.els-gms.att.net rname: rm-hostmaster.ems.att.com serial: 14 refresh: 10800 retry: 3600 expire: 604800 minimum-ttl: 86400 |
||
| sangart.com | IN | NS | 86400 | dbru.br.ns.els-gms.att.net | ||
| sangart.com | IN | NS | 86400 | dmtu.mt.ns.els-gms.att.net |
Server Location
Site source
Show / hide source
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en-US" lang="en-US"><head><title>Sangart</title><meta http-equiv="X-UA-Compatible" content="IE=7" /><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta http-equiv="Content-Language" content="en-US" /><meta http-equiv="Content-Script-Type" content="text/javascript" /><meta http-equiv="Content-Style-Type" content="text/css" /><meta http-equiv="imagetoolbar" content="no" /><meta name="keywords" content="" lang="en-US" /><meta name="description" content="" lang="en-US" /><meta name="copyright" content="" lang="en-US" /><meta name="generator" content="PINT [ www.pint.com ]" lang="en-US" /><meta name="author" content="PINT [ www.pint.com ]" lang="en-US" /><link rel="Shortcut Icon" href="/favicon.ico" /><link rel="stylesheet" href="assets/css/common.css" type="text/css" media="screen" /><link rel="stylesheet" href="assets/css/print.css" type="text/css" media="print" /><!--[if lte IE 7]><link rel="stylesheet" href="assets/css/ie7.css" type="text/css" media="screen" /><![endif]--><!--[if lt IE 7]><link rel="stylesheet" href="assets/css/ie6.css" type="text/css" media="screen" /><![endif]--><script src="assets/scripts/common.js" type="text/javascript"></script></head><body class="home"><a id="top"></a><p id="skip"><a href="#content">Skip to content</a></p><div id="wrap"><div id="container"> <div id="header">
<img src="assets/images/logo.png" alt="Sangart" width="228" height="109" id="logo" /> <ul id="nav" class="nav">
<li class="company"><a href="company">Company<strong> </strong><!--[if IE 7]><!--></a><!--<![endif]--><!--[if lte IE 6]><table cellspacing="0"><tr><td><![endif]-->
<ul>
<li><a href="company/history.htm">History</a></li>
<li><a href="company/management.htm">Management Team</a></li>
<li><a href="company/board.htm">Board of Directors</a></li>
<li><a href="company/investor.htm">Investor Relations</a></li>
<li><a href="company/business_development.htm">Business Development</a></li>
<li><a href="company/career.htm">Career Opportunities</a></li>
</ul><!--[if lte IE 6]></td></tr></table></a><![endif]-->
</li>
<li class="products"><a href="products/">Products<strong> </strong><!--[if IE 7]><!--></a><!--<![endif]--><!--[if lte IE 6]><table cellspacing="0"><tr><td><![endif]--> <ul> <li><a href="products/mp4ox.htm">MP4OX</a></li> <li><a href="products/mp4co.htm">MP4CO</a></li> <li><a href="products/pipeline.htm">Pipeline</a></li> </ul><!--[if lte IE 6]></td></tr></table></a><![endif]--> </li> <li class="research"><a href="research/">Research<strong> </strong><!--[if IE 7]><!--></a><!--<![endif]--><!--[if lte IE 6]><table cellspacing="0"><tr><td><![endif]--> <ul> <li><a href="research/trauma.htm">Trauma</a></li> <li><a href="research/sickle.htm">Sickle Cell Anemia</a> <!-- <ul> <li><a href="research/sickle/advisory.htm">Advisory Board</a></li> <li><a href="research/sickle/trials.htm">Clinical Trials</a></li> </ul> --> </li> <li><a href="research/other.htm">Other Conditions</a> <!-- <ul> <li><a href="research/other/advisory.htm">Advisory Board</a></li> <li><a href="research/other/trials.htm">Clinical Trials</a></li> </ul> --> </li> <li><a href="research/trials.htm">Clinical Trials</a></li> <li><a href="research/relevant_literature.htm">Relevant Literature</a></li> </ul><!--[if lte IE 6]></td></tr></table></a><![endif]--> </li> <li class="newsroom"><a href="newsroom/">Newsroom<strong> </strong></a></li> <li class="contact"><a href="contact/">Contact<strong> </strong></a> </li> </ul> <form action="http://biz54.inmotionhosting.com/~sangar6/isearch2/index.php" method="get"> <input type="text" id="search" name="s" value="Search" /> <input type="submit" class="btn" value="Go" title="Search" /> </form>
</div><!--// ENDS HEADER -->
<div id="content">
<div id="h_flash">
<img src="assets/images/banner-innovative-medicines.jpg" width="990" height="292" alt="Aiming to provide patients with innovative life-saving medicines" />
</div>
<script type="text/javascript">
var oSwf1 = new PINT.util.flash({
"id" : "h_flash",
"swf" : "assets/flash/h-flash.swf",
"noscriptId" : "h_flash",
"width" : 990,
"height" : 292,
"defaultimage" : "assets/images/banner-innovative-medicines.jpg"
});
oSwf1.addParam('wmode', 'transparent');
oSwf1.render('h_flash');
</script>
<div class="h1_bg clearfix"><h1>Sangart is a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen delivery. <a href="company/index.htm"><img src="assets/images/btn_learnmore.gif" width="198" height="28" alt="Learn More About Sangart" title="Learn more about Sangart" class="h_learnmore" border="0" /></a></h1> </div> <ul id="h_cols"> <li class="products"><div class="inner"><div class="inner"> <h2>Products</h2> <a href="products/" class="more">More</a><br /> <p class="summary">During more than 30 years of extensive research, Sangart has refined the pegylation of human hemoglobin to create a proprietary molecule, MP4, with the ability to perfuse oxygen deprived tissues and carry oxygen through the circulatory system to prevent and treat ischemia (oxygen deprivation of tissues).</p> <h3><a href="products/mp4ox.htm">MP4OX</a></h3><p>MP4OX is designed to deliver oxygen in the capillaries, where red blood cells may not naturally reach when the body is suffering from trauma-related ischemia. <a href="/assets/flash/animation.flv" class="pintbox pintbox-width-750 pintbox-height-422" title="Sangart Animation"><strong>Please click here for a short animation describing MP4OX's unique mechanism of action.</strong></a> </p> <h3><a href="products/mp4co.htm">MP4CO</a></h3><p>MP4CO is designed to deliver therapeutic levels of carbon monoxide (CO) and then provide oxygen delivery for patients with sickle cell anemia suffering from a sickle cell crisis.</p> <h3><a href="products/pipeline.htm">Product Pipeline</a></h3><p> Sangart is developing a number of additional, earlier stage pipeline products based on its core technology and unique understanding of oxygen delivery.</p>
</div></div></li>
<li class="research"><div class="inner"><div class="inner"> <h2>Research</h2> <a href="research/" class="more">More</a><br /> <p class="summary">Built on a strong foundation of scientific research, Sangart is dedicated to continuing its comprehensive clinical trial program to study and develop its products for patients in need.</p><br /> <h3><a href="research/trauma.htm">Trauma</a></h3><p>Studying MP4OX's ability to benefit patients suffering from trauma.</p>
<h3><a href="research/sickle.htm">Sickle Cell Anemia</a></h3><p>Studying MP4CO's ability to benefit sickle cell anemia patients.</p><a href="http://www.ivanhoe.com/science/story/2009/12/654a.html"><strong>Please click here for a broadcast segment on sickle cell disease featuring Sangart.</a></p> <h3><a href="research/other.htm">Other Conditions</a></h3>
<h3><a href="research/trials.htm">Clinical Trials</a></h3>
</div></div></li> <li class="news"><div class="inner"><div class="inner"> <h2>Latest News</h2>
<p><em>15 Feb 2012</em><br />
<a href="newsroom/press_021512.htm">Sangart Enhances Leadership Team Bringing Superior Depth of Expertise</a></p>
<p><em>12 Jan 2012</em><br />
<a href="newsroom/press_011212.htm">Sangart Initiates Phase 1b Study of MP4CO in Patients with Sickle Cell Disease</a></p>
<p><em>14 June 2011</em><br />
<a href="newsroom/press_061411.htm">Sangart Initiates Phase 2b Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients with Hemorrhagic Shock</a></p>
<p><a href="newsroom/" class="more">More</a><br />
</p>
</div>
</div></li> </ul> </div><!--// ENDS CONTENT --> <div id="footer"> <ul> <li><a href="company/">Company</a></li> <li><a href="sitemap/">Site Map</a></li> <li><a href="privacy/">Privacy Policy</a></li> <li class="last"><a href="terms/">Terms of Use</a></li> </ul> <p>Copyright © 2009-2011 Sangart Inc.</p> </div><!--// ENDS FOOTER --></div></div><!--// ENDS CONTAINER/WRAP --><!-- BEGIN WEBSIDESTORY CODE v3.0.0 (pro)--><!-- COPYRIGHT 1997-2003 WEBSIDESTORY, INC. ALL RIGHTS RESERVED. U.S.PATENT No. 6,393,479 B1. Privacy notice at: http://websidestory.com/privacy --><script language="javascript">var _pn="<?= $hitBoxPageName?$hitBoxPageName:'Index'; ?>"; //page name(s)var _mlc="<?= $hitBoxContentCategory?$hitBoxContentCategory:'Home'; ?>"; //multi-level content categoryvar _cp="null"; //campaignvar _acct="<?= $hitBoxAccountID ?>"; //account number(s)var _pndef="title"; //default page namevar _ctdef="full"; //default content categoryvar _prc=""; //commerce pricevar _oid=""; //commerce ordervar _dlf=""; //download filtervar _elf=""; //exit link filtervar _epg=""; //event page identifiervar _mn="<?= $hitBoxMachineName ?>"; //machine namevar _gn="phg.hitbox.com"; //gateway namevar _hcv=68;function _wn(n){return((n.indexOf("NAME")>0&&n.indexOf("PUT")>-1)||(n.indexOf("CONTENT")>-1&&n.indexOf("CATEGORY")>0))};function _gd(x,w){var _ed=x.lastIndexOf("/");var _be=(w!="full")?x.lastIndexOf("/",_ed-2):x.indexOf("/");return(_be==_ed)?"/":x.substring(_be,_ed);};function _gf(x){return x.substring(x.lastIndexOf("/")+1,x.length);};var _hl=location;var _lp=_hl.protocol.indexOf('https')>-1?'https://':'http://';var _zo=(new Date()).getTimezoneOffset();function _ps(_ip,_pml){return(_ip&&_wn(_pml))?((_pndef=="title"&&document.title!="")?document.title:_gf(_hl.pathname)?_gf(_hl.pathname):_pndef):(_wn(_pml)?_gd(_hl.pathname,_ctdef):_pml)};function _pm(m,_fml,h){if(m.indexOf(";")!=-1){_nml=m.substring(0,m.indexOf(";"));_rm=m.substring(m.indexOf(";")+1,m.length);_fml+=_ps(h,_nml)+";";return _pm(_rm,_fml,h);}else{return _fml+_ps(h,m);}};var _sv=10;var _hn=navigator;var _bn=_hn.appName;if(_bn.substring(0,9)=="Microsoft"){_bn="MSIE";};var _bv=(Math.round(parseFloat(_hn.appVersion)*100));if((_bn=="MSIE")&&(parseInt(_bv)==2))_bv=301;function _ex(v){return escape(v)};var _rf=_ex(document.referrer);_mlc=_pm(_mlc,"",0);_pn=_pm(_pn,"",1);</script><script language="javascript1.1">_sv=11</script><script language="javascript1.1" src="http://stats.hitbox.com/js/hbp.js" defer></script><script language="javascript">if(_sv<11){if(document.cookie.indexOf("CP=")>-1){_ce="y";}else{document.cookie="CP=null*; path=/; expires=Wed, 1 Jan 2020 00:00:00 GMT";_ce=(document.cookie.indexOf("CP=")!=-1)?"y":"n";};if((_rf=="undefined")||(_rf=="")){_rf="bookmark";};_x2="<img src='"+_lp+_gn+"/HG?hc="+_mn+"&hb="+_ex(_acct)+"&n="+_ex(_pn);_x3="&cd=1&hv=6' border=0 height=1 width=1>";_ar="&bn="+_ex(_bn)+"&bv="+_bv+"&ce="+_ce+"&ss=na&sc=na&ja=na&sv="+_sv+"&con="+_ex(_mlc)+"&vcon="+_ex(_mlc)+"&epg="+_epg+"&hp=u&cy=u&dt=&ln=na&cp="+_ex(_cp)+"&pl=&prc="+_ex(_prc)+"&oid="+_ex(_oid)+"&rf="+_rf;document.write(_x2+_ar+_x3);}if(_bn!='Netscape'&&_bv>399)document.write("<\!"+"--");</script><noscript><img src="http://phg.hitbox.com/HG?hc=<?= $hitBoxMachineName ?>&cd=1&hv=6&ce=u&hb=<?= $hitBoxAccountID ?>&n=<?= $hitBoxPageName?$hitBoxPageName:'Index'; ?>&vcon=<?= $hitBoxContentCategory?$hitBoxContentCategory:'Home'; ?>" alt='' border='0' width='1' height='1' /></noscript><!--//--><!-- END WEBSIDESTORY CODE --></body></html>